Patients were randomized into two groups : A - ( Aranesp group ) : HD patients on Eprex Q TIW or BIW were converted to Aranesp Q weekly , by using the conversion factor of 200:1 and those on Eprex Q weekly to Aranesp Q 2 weeks ; B - ( Eprex group ) : patients continued on Eprex treatment .